PortfoliosLab logoPortfoliosLab logo
TBRG vs. NAGE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TBRG vs. NAGE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TruBridge Inc (TBRG) and Niagen Bioscience, Inc (NAGE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TBRG achieves a 18.31% return, which is significantly higher than NAGE's -46.38% return. Over the past 10 years, TBRG has underperformed NAGE with an annualized return of -2.72%, while NAGE has yielded a comparatively higher 1.67% annualized return.


TBRG

1D
0.08%
1M
0.66%
YTD
18.31%
6M
20.43%
1Y
16.56%
3Y*
1.80%
5Y*
-4.71%
10Y*
-2.72%

NAGE

1D
-2.57%
1M
-6.83%
YTD
-46.38%
6M
-49.18%
1Y
-74.63%
3Y*
27.64%
5Y*
-17.53%
10Y*
1.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TBRG vs. NAGE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TBRG
TruBridge Inc
18.31%11.92%76.07%-58.85%-7.10%9.17%2.84%6.78%-15.30%31.11%
NAGE
Niagen Bioscience, Inc
-46.38%19.89%270.98%-14.88%-55.08%-22.08%11.37%25.66%-41.67%77.64%

Correlation

The correlation between TBRG and NAGE is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jul 15, 2008

0.10

The correlation between TBRG and NAGE shifts across timeframes, from 0.07 (3 years) to 0.18 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TBRG:

$378.28M

NAGE:

$288.37M

EPS

TBRG:

$0.30

NAGE:

$0.22

PE Ratio

TBRG:

86.92

NAGE:

15.64

PS Ratio

TBRG:

1.09

NAGE:

2.23

PB Ratio

TBRG:

2.13

NAGE:

3.50

Total Revenue (TTM)

TBRG:

$346.84M

NAGE:

$130.42M

Gross Profit (TTM)

TBRG:

$183.86M

NAGE:

$83.83M

EBITDA (TTM)

TBRG:

$57.80M

NAGE:

$13.37M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TBRG vs. NAGE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TBRG
TBRG Risk / Return Rank: 5454
Overall Rank
TBRG Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
TBRG Sortino Ratio Rank: 5353
Sortino Ratio Rank
TBRG Omega Ratio Rank: 5454
Omega Ratio Rank
TBRG Calmar Ratio Rank: 5252
Calmar Ratio Rank
TBRG Martin Ratio Rank: 5555
Martin Ratio Rank

NAGE
NAGE Risk / Return Rank: 33
Overall Rank
NAGE Sharpe Ratio Rank: 11
Sharpe Ratio Rank
NAGE Sortino Ratio Rank: 00
Sortino Ratio Rank
NAGE Omega Ratio Rank: 11
Omega Ratio Rank
NAGE Calmar Ratio Rank: 22
Calmar Ratio Rank
NAGE Martin Ratio Rank: 99
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TBRG vs. NAGE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TruBridge Inc (TBRG) and Niagen Bioscience, Inc (NAGE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TBRGNAGEDifference
Sharpe ratioReturn per unit of total volatility

+1.88

Sortino ratioReturn per unit of downside risk

+3.77

Omega ratioGain probability vs. loss probability

1.12

0.66

+0.47

Calmar ratioReturn relative to maximum drawdown

0.41

-0.98

+1.38

Martin ratioReturn relative to average drawdown

1.14

-1.36

+2.50

TBRG vs. NAGE - Sharpe Ratio Comparison

The current TBRG Sharpe Ratio is 0.40, which is higher than the NAGE Sharpe Ratio of -1.48. The chart below compares the historical Sharpe Ratios of TBRG and NAGE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TBRG vs. NAGE - Drawdown Comparison

The maximum TBRG drawdown since its inception was -86.87%, smaller than the maximum NAGE drawdown of -97.00%. Use the drawdown chart below to compare losses from any high point for TBRG and NAGE.


Loading charts...

Drawdown Indicators


TBRGNAGEDifference

Max Drawdown

Largest peak-to-trough decline

-86.87%

-97.00%

+10.13%

Max Drawdown (1Y)

Largest decline over 1 year

-40.73%

-76.61%

+35.88%

Max Drawdown (3Y)

Largest decline over 3 years

-71.31%

-76.61%

+5.30%

Max Drawdown (5Y)

Largest decline over 5 years

-79.46%

-88.57%

+9.11%

Max Drawdown (10Y)

Largest decline over 10 years

-79.70%

-93.65%

+13.95%

Current Drawdown

Current decline from peak

-55.19%

-81.80%

+26.61%

Average Drawdown

Average peak-to-trough decline

-35.85%

-75.72%

+39.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.61%

54.82%

-40.21%

Volatility

TBRG vs. NAGE - Volatility Comparison

The current volatility for TruBridge Inc (TBRG) is 0.54%, while Niagen Bioscience, Inc (NAGE) has a volatility of 12.97%. This indicates that TBRG experiences smaller price fluctuations and is considered to be less risky than NAGE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TBRGNAGEDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.54%

12.97%

-12.43%

Volatility (6M)

Calculated over the trailing 6-month period

33.92%

34.75%

-0.83%

Volatility (1Y)

Calculated over the trailing 1-year period

41.83%

50.62%

-8.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.82%

76.86%

-34.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.05%

78.77%

-36.72%

Dividends

TBRG vs. NAGE - Dividend Comparison

Neither TBRG nor NAGE has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
NAGE
Niagen Bioscience, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TBRG
TruBridge Inc
0.00%0.00%0.00%0.00%0.00%0.00%1.12%1.52%1.59%2.83%7.88%5.15%

Financials

TBRG vs. NAGE - Financials Comparison

This section allows you to compare key financial metrics between TruBridge Inc and Niagen Bioscience, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00M40.00M60.00M80.00M100.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
87.79M
31.47M
(TBRG) Total Revenue
(NAGE) Total Revenue
Values in USD except per share items

TBRG vs. NAGE - Profitability Comparison

The chart below illustrates the profitability comparison between TruBridge Inc and Niagen Bioscience, Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

45.0%50.0%55.0%60.0%65.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
54.3%
63.5%
Portfolio components
TBRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TruBridge Inc reported a gross profit of 47.65M and revenue of 87.79M. Therefore, the gross margin over that period was 54.3%.

NAGE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Niagen Bioscience, Inc reported a gross profit of 19.98M and revenue of 31.47M. Therefore, the gross margin over that period was 63.5%.

TBRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TruBridge Inc reported an operating income of 4.98M and revenue of 87.79M, resulting in an operating margin of 5.7%.

NAGE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Niagen Bioscience, Inc reported an operating income of 1.58M and revenue of 31.47M, resulting in an operating margin of 5.0%.

TBRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TruBridge Inc reported a net income of -4.29M and revenue of 87.79M, resulting in a net margin of -4.9%.

NAGE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Niagen Bioscience, Inc reported a net income of 6.32M and revenue of 31.47M, resulting in a net margin of 20.1%.


Frequently Asked Questions


TBRG and NAGE have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NAGE has higher volatility (12.97%) compared to TBRG (0.54%). In terms of maximum drawdown, TBRG dropped -86.87% vs NAGE's -97.00%.

TBRG currently has the higher Sharpe Ratio (0.40 vs -1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TBRG and NAGE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer